Stay updated on Rituximab and Hyaluronidase in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Rituximab and Hyaluronidase in Melanoma Clinical Trial page.

Latest updates to the Rituximab and Hyaluronidase in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed; this appears to be an administrative footer update and does not alter the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer displays the disclaimer about potential data not being up to date due to funding; the funding-status notice text has been removed.SummaryDifference0.4%

- Check42 days agoChange DetectedThe screenshots show an updated 'Results First Posted' date of 2025-04-22 and a newer 'Last Update' timestamp, while the study description and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

- Check78 days agoChange DetectedUpdated version tag to v3.1.0; removed explicit mention of an older revision v3.0.2. No other substantive content changes detected.SummaryDifference0.2%

- Check92 days agoChange DetectedUpdated revision to v3.0.2 and removed the Back to Top element; no core content or critical information is affected.SummaryDifference0.2%

Stay in the know with updates to Rituximab and Hyaluronidase in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab and Hyaluronidase in Melanoma Clinical Trial page.